37280636|t|Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer's Disease drug candidate.
37280636|a|BACKGROUND: Apolipoprotein E (ApoE) epsilon4 genotype is the most prevalent risk factor for late-onset Alzheimer's Disease (AD). Although ApoE4 differs from its non-pathological ApoE3 isoform only by the C112R mutation, the molecular mechanism of its proteinopathy is unknown. METHODS: Here, we reveal the molecular mechanism of ApoE4 aggregation using a combination of experimental and computational techniques, including X-ray crystallography, site-directed mutagenesis, hydrogen-deuterium mass spectrometry (HDX-MS), static light scattering and molecular dynamics simulations. Treatment of ApoE epsilon3/epsilon3 and epsilon4/epsilon4 cerebral organoids with tramiprosate was used to compare the effect of tramiprosate on ApoE4 aggregation at the cellular level. RESULTS: We found that C112R substitution in ApoE4 induces long-distance (> 15 A) conformational changes leading to the formation of a V-shaped dimeric unit that is geometrically different and more aggregation-prone than the ApoE3 structure. AD drug candidate tramiprosate and its metabolite 3-sulfopropanoic acid induce ApoE3-like conformational behavior in ApoE4 and reduce its aggregation propensity. Analysis of ApoE epsilon4/epsilon4 cerebral organoids treated with tramiprosate revealed its effect on cholesteryl esters, the storage products of excess cholesterol. CONCLUSIONS: Our results connect the ApoE4 structure with its aggregation propensity, providing a new druggable target for neurodegeneration and ageing.
37280636	22	27	C112R	ProteinMutation	tmVar:p|SUB|C|112|R;HGVS:p.C112R;VariantGroup:0;CorrespondingGene:348;CorrespondingSpecies:9606
37280636	40	45	ApoE4	Gene	348
37280636	79	98	Alzheimer's Disease	Disease	MESH:D000544
37280636	127	143	Apolipoprotein E	Gene	348
37280636	145	149	ApoE	Gene	348
37280636	218	237	Alzheimer's Disease	Disease	MESH:D000544
37280636	239	241	AD	Disease	MESH:D000544
37280636	253	258	ApoE4	Gene	348
37280636	293	298	ApoE3	Gene	348
37280636	319	324	C112R	ProteinMutation	tmVar:p|SUB|C|112|R;HGVS:p.C112R;VariantGroup:0;CorrespondingGene:348;CorrespondingSpecies:9606
37280636	366	379	proteinopathy	Disease	MESH:D057165
37280636	444	449	ApoE4	Gene	348
37280636	588	596	hydrogen	Chemical	MESH:D006859
37280636	708	712	ApoE	Gene	348
37280636	777	789	tramiprosate	Chemical	MESH:C001355
37280636	824	836	tramiprosate	Chemical	MESH:C001355
37280636	840	845	ApoE4	Gene	348
37280636	904	909	C112R	ProteinMutation	tmVar:p|SUB|C|112|R;HGVS:p.C112R;VariantGroup:0;CorrespondingGene:348;CorrespondingSpecies:9606
37280636	926	931	ApoE4	Gene	348
37280636	1106	1111	ApoE3	Gene	348
37280636	1123	1125	AD	Disease	MESH:D000544
37280636	1141	1153	tramiprosate	Chemical	MESH:C001355
37280636	1173	1194	3-sulfopropanoic acid	Chemical	-
37280636	1202	1207	ApoE3	Gene	348
37280636	1240	1245	ApoE4	Gene	348
37280636	1297	1301	ApoE	Gene	348
37280636	1352	1364	tramiprosate	Chemical	MESH:C001355
37280636	1388	1406	cholesteryl esters	Chemical	MESH:D002788
37280636	1439	1450	cholesterol	Chemical	MESH:D002784
37280636	1489	1494	ApoE4	Gene	348
37280636	1575	1592	neurodegeneration	Disease	MESH:D019636
37280636	Negative_Correlation	MESH:D000544	HGVS:p.C112R;CorrespondingGene:348
37280636	Association	MESH:D057165	348
37280636	Association	MESH:D002788	348
37280636	Association	MESH:D000544	348
37280636	Negative_Correlation	MESH:C001355	348
37280636	Association	MESH:D019636	348
37280636	Association	MESH:C001355	MESH:D002784
37280636	Association	MESH:C001355	MESH:D002788

